Omeros (OMER) Net Cash Flow (2010 - 2026)
Omeros recorded quarterly Net Cash Flow of -$7.8 million in Q1 2026, down 206.73% quarter-over-quarter from $7.3 million in Q4 2025, and down 1000.58% year-over-year from $861000.0 in Q1 2025.
Omeros' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$7.8 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 1000.58% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 196.91% YoY), while the FY2025 annual figure was $6.3 million, up 268.96% from the prior year.
- Net Cash Flow came in at -$7.8 million for Q1 2026 at Omeros, down from $7.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $131.4 million in Q3 2022 to a low of -$134.5 million in Q4 2022.
- A 5-year average of -$5.8 million and a median of $289000.0 in 2024 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 2585.28% in 2022 and fell as far as 6135.23% in 2022.
- Omeros' Net Cash Flow stood at -$134.5 million in 2022, then jumped by 82.5% to -$23.5 million in 2023, then surged by 107.98% to $1.9 million in 2024, then soared by 286.64% to $7.3 million in 2025, then plunged by 206.73% to -$7.8 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$7.8 million, $7.3 million, and $512000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -7.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.75 Mn |
| Mar 31, 2026 | -7.75 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 512,000.00 |
| Sep 30, 2025 | 512,000.00 |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 861,000.00 |
| Mar 31, 2025 | 861,000.00 |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | -599,000.00 |
| Sep 30, 2024 | -599,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Mar 31, 2024 | -5.27 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -23.54 Mn |
| Dec 31, 2023 | -23.54 Mn |
| Sep 30, 2023 | 24.04 Mn |
| Sep 30, 2023 | 24.04 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | -7.18 Mn |
| Mar 31, 2023 | -7.18 Mn |
| Dec 31, 2022 | -134.52 Mn |
| Dec 31, 2022 | -134.52 Mn |
| Sep 30, 2022 | 131.40 Mn |
| Sep 30, 2022 | 131.40 Mn |
| Jun 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | 5.17 Mn |
| Mar 31, 2022 | -91.85 Mn |
| Mar 31, 2022 | -91.85 Mn |
| Dec 31, 2021 | 93.39 Mn |
| Dec 31, 2021 | 93.39 Mn |
| Sep 30, 2021 | -5.29 Mn |
| Sep 30, 2021 | -5.29 Mn |
| Jun 30, 2021 | 3.67 Mn |
| Jun 30, 2021 | 3.67 Mn |
| Mar 31, 2021 | -1.47 Mn |
| Mar 31, 2021 | -1.47 Mn |
| Dec 31, 2020 | -10.57 Mn |
| Dec 31, 2020 | -10.57 Mn |
| Sep 30, 2020 | 19.11 Mn |
| Sep 30, 2020 | 19.11 Mn |
| Jun 30, 2020 | -5.15 Mn |
| Jun 30, 2020 | -5.15 Mn |
| Mar 31, 2020 | 4.03 Mn |
| Mar 31, 2020 | 4.03 Mn |
| Dec 31, 2019 | -5.78 Mn |
| Dec 31, 2019 | -5.78 Mn |
| Sep 30, 2019 | 4.88 Mn |
| Sep 30, 2019 | 4.88 Mn |
| Jun 30, 2019 | -68,000.00 |
| Jun 30, 2019 | -68,000.00 |
| Mar 31, 2019 | -1.81 Mn |
| Mar 31, 2019 | -1.81 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Sep 30, 2018 | -96,000.00 |
| Sep 30, 2018 | -96,000.00 |
| Jun 30, 2018 | 1.69 Mn |
| Jun 30, 2018 | 1.69 Mn |
| Mar 31, 2018 | -2.21 Mn |
| Mar 31, 2018 | -2.21 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Sep 30, 2017 | -2.36 Mn |
| Sep 30, 2017 | -2.36 Mn |
| Jun 30, 2017 | 2.10 Mn |
| Jun 30, 2017 | 2.10 Mn |
| Mar 31, 2017 | -942,000.00 |
| Mar 31, 2017 | -942,000.00 |
| Dec 31, 2016 | -8.07 Mn |
| Dec 31, 2016 | -8.07 Mn |
| Sep 30, 2016 | 5.71 Mn |
| Sep 30, 2016 | 5.71 Mn |
| Jun 30, 2016 | 3.61 Mn |
| Jun 30, 2016 | 3.61 Mn |
| Mar 31, 2016 | -387,000.00 |
| Mar 31, 2016 | -387,000.00 |
| Dec 31, 2015 | 764,000.00 |
| Dec 31, 2015 | 764,000.00 |
| Sep 30, 2015 | -1.96 Mn |
| Sep 30, 2015 | -1.96 Mn |
| Jun 30, 2015 | 1.12 Mn |
| Jun 30, 2015 | 1.12 Mn |
| Mar 31, 2015 | 1.09 Mn |
| Mar 31, 2015 | 1.09 Mn |
| Dec 31, 2014 | -396,000.00 |
| Dec 31, 2014 | -396,000.00 |
| Sep 30, 2014 | -783,000.00 |
| Sep 30, 2014 | -783,000.00 |
| Jun 30, 2014 | 966,000.00 |
| Jun 30, 2014 | 966,000.00 |
| Mar 31, 2014 | -817,000.00 |
| Mar 31, 2014 | -817,000.00 |
| Dec 31, 2013 | 234,000.00 |
| Dec 31, 2013 | 234,000.00 |
| Sep 30, 2013 | -566,000.00 |
| Sep 30, 2013 | -566,000.00 |
| Jun 30, 2013 | 435,000.00 |
| Jun 30, 2013 | 435,000.00 |
| Mar 31, 2013 | -239,000.00 |
| Mar 31, 2013 | -239,000.00 |
| Dec 31, 2012 | 460,000.00 |
| Dec 31, 2012 | 460,000.00 |
| Sep 30, 2012 | -6.21 Mn |
| Sep 30, 2012 | -6.21 Mn |
| Jun 30, 2012 | -9.53 Mn |
| Jun 30, 2012 | -9.53 Mn |
| Mar 31, 2012 | 12.80 Mn |
| Mar 31, 2012 | 12.80 Mn |
| Dec 31, 2011 | -883,000.00 |
| Dec 31, 2011 | -883,000.00 |
| Sep 30, 2011 | 729,000.00 |
| Sep 30, 2011 | 729,000.00 |
| Jun 30, 2011 | 238,000.00 |
| Jun 30, 2011 | 238,000.00 |
| Mar 31, 2011 | 643,000.00 |
| Mar 31, 2011 | 643,000.00 |
| Dec 31, 2010 | 482,000.00 |
| Dec 31, 2010 | 482,000.00 |
| Sep 30, 2010 | -77,000.00 |
| Sep 30, 2010 | -77,000.00 |